Reduction of daily maintenance inhaled corticosteroids in patients with severe eosinophilic asthma treated with benralizumab (SHAMAL): a randomised, multicentre, open-label, phase 4 study
Titel:
Reduction of daily maintenance inhaled corticosteroids in patients with severe eosinophilic asthma treated with benralizumab (SHAMAL): a randomised, multicentre, open-label, phase 4 study
Auteur:
Jackson, David J Heaney, Liam G Humbert, Marc Kent, Brian D Shavit, Anat Hiljemark, Lina Olinger, Lynda Cohen, David Menzies-Gow, Andrew Korn, Stephanie
Verschenen in:
Lancet
Paginering:
Jaargang 403 () nr. 10423 pagina's 271-281
Jaar:
2024
Inhoud:
Uitgever:
The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license